English to Chinese Simplified Life Sciences / Pharmacovigilance Linguist (US Timezone)

About Welo Life Sciences 

Welo Life Sciences, a Welo Global brand, is a specialized language and technology partner serving pharmaceutical, CRO, and medical device organizations operating in regulated global markets. We deliver regulator-ready translation, linguistic validation, and localization solutions that support clinical trials, pharmacovigilance, regulatory affairs, labeling, and global commercialization. Our approach combines subject matter expertise with ISO-certified quality processes and technology-enabled workflows designed to integrate seamlessly into life sciences operations. With extensive experience supporting global product development and post-market requirements, Welo Life Sciences helps organizations accelerate timelines, protect data integrity, and maintain compliance across languages and regions. All solutions are delivered within a secure, audit-ready framework supported by seven ISO certifications.  welolifesciences.com

About the Role

We are looking for experienced English into Chinese Simplified linguists either based in United States or that could cover US time zone to support a new, high-volume pharmacovigilance program for a leading global pharmaceutical company. The program centers on Periodic Benefit-Risk Evaluation Reports (PBRERs) and carries a strict, non-extendable 24-hour turnaround time, including weekends.

This is a new engagement expected to start end of August 2026, running as an ongoing freelance engagement with regular volumes of 30,000–60,000 words per project.

Key Responsibilities

• Perform Machine Translation Post-Editing (MTPE) of Periodic Benefit-Risk Evaluation Reports (PBRERs) and regulatory document evaluating a medicine's cumulative safety, efficacy, and benefit-risk balance and related pharmacovigilance content from English into Chinese Simplified.
• Meet a strict, non-extendable 24-hour turnaround time; project requests may arrive any time of day, including weekends.
• Work within the client's CAT tool environment (XTM) following project-specific setup instructions.
• Collaborate with other linguists on the same project when volumes require work to be split across multiple resources to meet deadlines, while maintaining consistency and quality.

Requirements

• Degree in translation, linguistics or languages studies or an equivalent degree that includes significant 
  translation training.
• Minimum 2 years of professional experience translating Pharmacovigilance documents: SAE/AE (serious and non-serious adverse events), PSURs (Periodic Safety Update Reports), SUSARs (Suspected Unexpected Serious Adverse Reactions), ICSRs (Individual Case Safety Reports), DSURs (Development Safety Update Reports), or Risk Management Plans (RMPs).
• Alternatively, minimum 2 years of experience translating regulatory or clinical documents such as medical reports, protocols, synopses, ICF, discharge reports, study reports, SmPC, PIL, or medical literature (articles/journals).
• Able to commit at least 5 hours daily, including weekends, given the strict 24-hour TAT.
• Comfortable working as part of a linguist pool on the same project, to meet volume and deadline requirements consistently.
• Familiarity with CAT tools, XTM will be used and will be plus to have previous experience!
• Reliable, deadline-driven, and available on short notice, project requests may come in at any time.
• Based in the United States, or otherwise able to consistently cover US business hours. 

Nice to Have

• Prior experience on dedicated/embedded pharmacovigilance or safety programs with strict SLA-based delivery.
• Experience translating PBRERs specifically.
• Established capacity to track and report daily throughput for Operations/PM planning purposes.

Tools & Systems

• CAT tool: XTM, client-provided license; onboarding and connector setup provided after onboarding.
• There's an unpaid Pharmacovigilance test as part of our onboarding and quality process, please only apply if you're willing to complete it. 

Job Reference: #LI-JC1